Anticancer properties of Flavonoids: Roles in various stages of carcinogenesis

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 9, Issue 2, 2011, Pages 62-77

  Clere, Nicolas ^a   Faure, Sébastien ^a   Martinez, Maria Carmen ^a   Andriantsitohaina, Ramaroson ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

Angiogenesis; Apigenin; Carcinogenesis; Delphinidin; EGCG; Flavonoids; Genistein; Metastasis; Tumor initiation; Tumor microenvironment; Tumor progression

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; APIGENIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOCHROME C; DELPHINIDIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; FOCAL ADHESION KINASE 1; FREE RADICAL; GELATINASE B; GENISTEIN; INTERLEUKIN 12; KI 67 ANTIGEN; ONCOPROTEIN; ORNITHINE DECARBOXYLASE INHIBITOR; P21 ACTIVATED KINASE; POLYPHENOL; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P16; PROTEIN P27; REACTIVE OXYGEN METABOLITE; STEROID RECEPTOR COACTIVATOR 3; VASODILATOR AGENT;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CYTOTOXICITY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; DISEASE FREE SURVIVAL; DNA DAMAGE; ENDOTHELIUM CELL; ESOPHAGUS CANCER; HEALTH PROMOTION; HEART DISEASE; HUMAN; IN VIVO CULTURE; LUNG CANCER; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; SKIN CANCER; SKIN TUMOR; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FLAVONOIDS; HUMANS; NEOPLASMS; PLANTS;

EID: 79959941695     PISSN: 18715257     EISSN: 18756182     Source Type: Journal    
DOI: 10.2174/187152511796196498     Document Type: Article

References (175)

1. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5), 646-674.
2. Kroemer, G.; Pouyssegur, J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell, 2008, 13(6), 472-482.
3. Luo, J.; Solimini, N.L.; Elledge, S.J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell, 2009, 136(5), 823-837.
4. Colotta, F.; Allavena, P.; Sica, A.; Garlanda, C.; Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 2009, 30(7), 1073-1081.
5. Chung, F.L.; Schwartz, J.; Herzog, C.R.; Yang, Y.M. Tea and cancer prevention: studies in animals and humans. J. Nutr., 2003, 133(10), 3268S-3274S.
6. Bonfili, L.; Cecarini, V.; Amici, M.; Cuccioloni, M.; Angeletti, M.; Keller, J.N.; Eleuteri, A.M. Natural polyphenols as proteasome modulators and their role as anti-cancer compounds. FEBS J., 2008, 275(22), 5512-5526.
7. Pan, M.H.; Lai, C.S.; Wu, J.C.; Ho, C.T. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol. Nutr. Food Res., 2011, 55(1), 32-45.
8. Zhao, R.; Xiang, N.; Domann, F.E.; Zhong, W. Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutr. Cancer, 2009, 61(3), 397-407.
9. He, H.; Chen, L.; Zhai, M.; Chen, J.Z. Genistein down-regulates the constitutive activation of nuclear factor-kappaB in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Phytother. Res., 2009, 23(6), 868-873.
10. Hanahan, D.; Weinberg, R. The hallmarks of cancer. Cell, 2000, 100(1), 57-70.
11. Coleman, W.B.; Tsongalis, G.J. Molecular mechanisms of human carcinogenesis. EXS, 2006(96), 321-349.
12. Okada, H.; Mak, T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer, 2004, 4(8), 592-603.
13. Debatin, K.M.; Krammer, P.H. Death receptors in chemotherapy and cancer. Oncogene, 2004, 23(16), 2950-2966.
14. Folkman, J.; Shing, Y. Angiogenesis. J. Biol. Chem., 1992, 267(16), 10931-10934.
15. Risau, W. Mechanisms of angiogenesis. Nature., 1997, 386(6626), 671-674.
16. Friesel, R.; Maciag, T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J., 1995, 9(10), 919-925.
17. Battegay, E.; Rupp, J.; Iruela-Arispe, L.; Sage, E.; Pech, M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J. Cell. Biol., 1994, 125(4), 917-928.
18. Cao, R.; Bråkenhielm, E.; Li, X.; Pietras, K.; Widenfalk, J.; Ostman, A.; Eriksson, U.; Cao, Y. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB J., 2002, 16(12), 1575-1583.
19. Baeriswyl, V.; Christofori, G. The angiogenic switch in carcinogenesis. Semin. Cancer Biol., 2009, 19(5), 329-337.
20. Perrone, G.; Vincenzi, B.; Santini, D.; Verzì, A.; Tonini, G.; Vetrani, A.; Rabitti, C. Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer. Cancer Lett., 2004, 208(2), 227-234.
21. Clere, N.; Bermont, L.; Fauconnet, S.; Lascombe, I.; Saunier, M.; Vettoretti, L.; Plissonnier, M.L.; Mougin, C. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism. Exp. Cell Res., 2007, 313(15), 3239-3250.
22. Carmeliet, P.; Jain, R. Angiogenesis in cancer and other diseases. Nature, 2000, 407(6801), 249-257.
23. Chua, C.; Hamdy, R.; Chua, B. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic. Biol. Med., 1998, 25(8), 891-897.
24. Gerber, H.P.; Kowalski, J.; Sherman, D.; Eberhard, D.A.; Ferrara, N. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. Cancer Res., 2000, 60(22), 6253-6258.
25. Hida, K.; Klagsbrun, M. A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities. Cancer Res., 2005, 65(7), 2507-2510.
26. Morikawa, S.; Baluk, P.; Kaidoh, T.; Haskell, A.; Jain, R.K.; McDonald, D.M. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol., 2002, 160(3), 985-1000.
27. Sims, D.E. Diversity within pericytes. Clin. Exp. Pharmacol. Physiol., 2000, 27(10), 842-846.
28. Middleton, E.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52(4), 673-751.
29. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-747.
30. Curin, Y.; Ritz, M.F.; Andriantsitohaina, R. Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. Cardiovasc. Hematol. Agents. Med. Chem., 2006, 4(4), 277-288.
31. Lotito, S.B.; Frei, B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic. Biol. Med., 2006, 41(12), 1727-1746.
32. Gupta, S.; Afaq, F.; Mukhtar, H. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem. Biophys. Res. Commun., 2001, 287(4), 914-920.
33. Grove, K.A.; Lambert, J.D. Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity. J Nutr., 2010, 140(3), 446-453.
34. Kong, J.M.; Chia, L.S.; Goh, N.K.; Chia, T.F.; Brouillard, R. Analysis and biological activities of anthocyanins. Phytochemistry, 2003, 64(5), 923-933.
35. Martin, S.; Favot, L.; Matz, R.; Lugnier, C.; Andriantsitohaina, R. Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2. Biochem. Pharmacol., 2003, 65(4), 669-675.
36. Andriambeloson, E.; Magnier, C.; Haan-Archipoff, G.; Lobstein, A.; Anton, R.; Beretz, A.; Stoclet, J.C.; Andriantsitohaina, R. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J. Nutr., 1998, 128(12), 2324-2333.
37. Afaq, F.; Syed, D.N.; Malik, A.; Hadi, N.; Sarfaraz, S.; Kweon, M.H.; Khan, N.; Zaid, M.A.; Mukhtar, H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis. J. Invest. Dermatol., 2007, 127(1), 222-232.
38. Messina, M.; Nagata, C.; Wu, A.H. Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer., 2006, 55(1), 1-12.
39. Hwang, Y.W.; Kim, S.Y.; Jee, S.H.; Kim, Y.N.; Nam, C.M. Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr. Cancer, 2009, 61(5), 598-606.
40. Wu, A.H.; Ziegler, R.G.; Horn-Ross, P.L.; Nomura, A.M.; West, D.W.; Kolonel, L.N.; Rosenthal, J.F.; Hoover, R.N.; Pike, M.C. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomarkers Prev., 1996, 5(11), 901-906.
41. Bobe, G.; Sansbury, L.B.; Albert, P.S.; Cross, A.J.; Kahle, L.; Ashby, J.; Slattery, M.L.; Caan, B.; Paskett, E.; Iber, F.; Kikendall, J.W.; Lance, P.; Daston, C.; Marshall, J.R.; Schatzkin, A.; Lanza, E. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol. Biomarkers. Prev., 2008, 17(6), 1344-1353.
42. Sporn, M.B. Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res., 1991, 51(23 Pt 1), 6215-6218.
43. Iacoviello, L.; Santimone, I.; Latella, M.C.; de Gaetano, G.; Donati, M.B. Nutrigenomics: a case for the common soil between cardiovascular disease and cancer. Genes Nutr., 2008, 3(1), 19-24.
44. Watson, W.H.; Cai, J.; Jones, D.P. Diet and apoptosis. Annu. Rev. Nutr., 2000, 20, 485-505.
45. Wenzel, U.; Kuntz, S.; Brendel, M.D.; Daniel, H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res., 2000, 60(14), 3823-3831.
46. Yang, C.S.; Landau, J.M.; Huang, M.T.; Newmark, H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr., 2001, 21, 381-406.
47. Arts, I.C.; Jacobs, D.R.; Gross, M.; Harnack, L.J.; Folsom, A.R. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control, 2002, 13(4), 373-382.
48. Key, T.J.; Sharp, G.B.; Appleby, P.N.; Beral, V.; Goodman, M.T.; Soda, M.; Mabuchi, K. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br. J. Cancer, 1999, 81(7), 1248-1256.
49. Knekt, P.; Järvinen, R.; Seppänen, R.; Hellövaara, M.; Teppo, L.; Pukkala, E.; Aromaa, A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol., 1997, 146(3), 223-230.
50. Le Marchand, L.; Murphy, S.P.; Hankin, J.H.; Wilkens, L.R.; Kolonel, L.N. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst., 2000, 92(2), 154-160.
51. Birt, D.F.; Mitchell, D.; Gold, B.; Pour, P.; Pinch, H.C. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res., 1997, 17(1A), 85-91.
52. Afaq, F.; Adhami, V.M.; Ahmad, N.; Mukhtar, H. Botanical antioxidants for chemoprevention of photocarcinogenesis. Front. Biosci., 2002, 7, 784-792.
53. Meeran, S.M.; Mantena, S.K.; Elmets, C.A.; Katiyar, S.K. (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res., 2006, 66(10), 5512-5520.
54. Liu, J.D.; Chen, S.H.; Lin, C.L.; Tsai, S.H.; Liang, Y.C. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. J. Cell. Biochem., 2001, 83(4), 631-642.
55. Whitsett, T.; Carpenter, M.; Lamartiniere, C.A. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J. Carcinog., 2006, 5, 15.
56. Hafeez, B.B.; Siddiqui, I.A.; Asim, M.; Malik, A.; Afaq, F.; Adhami, V.M.; Saleem, M.; Din, M.; Mukhtar, H. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res., 2008, 68(20), 8564-8572.
57. Hsieh, C.Y.; Santell, R.C.; Haslam, S.Z.; Helferich, W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res., 1998, 58(17), 3833-3838.
58. Harper, C.E.; Cook, L.M.; Patel, B.B.; Wang, J.; Eltoum, I.A.; Arabshahi, A.; Shirai, T.; Lamartiniere, C.A. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate, 2009, 69(15), 1668-1682.
59. Iishi, H.; Tatsuta, M.; Baba, M.; Yano, H.; Sakai, N.; Akedo, H. Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in Wistar rats. Int. J. Cancer, 2000, 86(3), 416-420.
60. Gu, Y.; Zhu, C.F.; Dai, Y.L.; Zhong, Q.; Sun, B. Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma. World J. Gastroenterol., 2009, 15(39), 4952-4957.
61. Birt, D.F.; Walker, B.; Tibbels, M.G.; Bresnick, E. Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis, 1986, 7(6), 959-963.
62. Hashemi, M.; Nouri Long, M.; Entezari, M.; Nafisi, S.; Nowroozii, H. Anti-mutagenic and Pro-apoptotic effects of apigenin on human chronic lymphocytic leukemia cells. Acta. Med. Iran., 2010, 48(5), 283-288.
63. Kuo, M.L.; Lee, K.C.; Lin, J.K. Genotoxicities of nitropyrenes and their modulation by apigenin, tannic acid, ellagic acid and indole-3-carbinol in the Salmonella and CHO systems. Mutat. Res., 1992, 270(2), 87-95.
64. Kachadourian, R.; Day, B.J. Flavonoid-induced glutathione depletion: potential implications for cancer treatment. Free Radic. Biol. Med., 2006, 41(1), 65-76.
65. Klaunig, J.E.; Kamendulis, L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 2004, 44, 239-267.
66. Wang, I.K.; Lin-Shiau, S.Y.; Lin, J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer, 1999, 35(10), 1517-1525.
67. Morrissey, C.; O'Neill, A.; Spengler, B.; Christoffel, V.; Fitzpatrick, J.M.; Watson, R.W. Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells. Prostate, 2005, 63(2), 131-142.
68. Choi, S.I.; Jeong, C.S.; Cho, S.Y.; Lee, Y.S. Mechanism of apoptosis induced by apigenin in HepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase. Arch. Pharm. Res., 2007, 30(10), 1328-1335.
69. Wang, W.; Heideman, L.; Chung, C.S.; Pelling, J.C.; Koehler, K.J.; Birt, D.F. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol. Carcinog., 2000, 28(2), 102-110.
70. Zhong, Y.; Krisanapun, C.; Lee, S.H.; Nualsanit, T.; Sams, C.; Peungvicha, P.; Baek, S.J. Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur. J. Cancer, 2010, 46(18), 3365-3374.
71. Gupta, S.; Afaq, F.; Mukhtar, H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene, 2002, 21(23), 3727-3738.
72. Shukla, S.; Gupta, S. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Mol. Carcinog., 2004, 39(2), 114-126.
73. Lambert, J.D.; Elias, R.J. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch. Biochem. Biophys., 2010, 501(1), 65-72.
74. Srinivasan, P.; Suchalatha, S.; Babu, P.V.; Devi, R.S.; Narayan, S.; Sabitha, K.E.; Shyamala-Devi, C.S. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer. Chem. Biol. Interact., 2008, 172(3), 224-234.
75. Siddiqui, I.A.; Tarapore, R.S.; Mukhtar, H. Prevention of skin cancer by green tea: past, present and future. Cancer. Biol. Ther., 2009, 8(13), 1288-1291.
76. Santhosh, K.T.; Swarnam, J.; Ramadasan, K. Potent suppressive effect of green tea polyphenols on tobacco-induced mutagenicity. Phytomedicine, 2005, 12(3), 216-220.
77. Yang, C.S.; Wang, X.; Lu, G.; Picinich, S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer, 2009, 9(6), 429-439.
78. Singh, M.; Tyagi, S.; Bhui, K.; Prasad, S.; Shukla, Y. Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols. Invest. New Drugs, 2010, 28(3), 216-224.
79. Sah, J.F.; Balasubramanian, S.; Eckert, R.L.; Rorke, E.A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem., 2004, 279(13), 12755-12762.
80. Roy, P.; Nigam, N.; Singh, M.; George, J.; Srivastava, S.; Naqvi, H.; Shukla, Y. Tea polyphenols inhibit cyclooxygenase-2 expression and block activation of nuclear factor-kappa B and Akt in diethylnitrosoamine induced lung tumors in Swiss mice. Invest. New Drugs, 2010, 28(4), 466-471.
81. Na, H.K.; Surh, Y.J. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem. Toxicol., 2008, 46(4), 1271-1278.
82. Sang, S.; Lee, M.J.; Hou, Z.; Ho, C.T.; Yang, C.S. Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J. Agric. Food. Chem., 2005, 53(24), 9478-9484.
83. Vittal, R.; Selvanayagam, Z.E.; Sun, Y.; Hong, J.; Liu, F.; Chin, K.V.; Yang, C.S. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Mol. Cancer Ther., 2004, 3(9), 1091-1099.
84. Nakagawa, H.; Hasumi, K.; Woo, J.T.; Nagai, K.; Wachi, M. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis, 2004, 25(9), 1567-1574.
85. Elbling, L.; Weiss, R.M.; Teufelhofer, O.; Uhl, M.; Knasmueller, S.; Schulte-Hermann, R.; Berger, W.; Micksche, M. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB. J., 2005, 19(7), 807-809.
86. Yang, W.H.; Fong, Y.C.; Lee, C.Y.; Jin, T.R.; Tzen, J.T.; Li, T.M.; Tang, C.H. Epigallocatechin-3-gallate induces cell apoptosis of human chondrosarcoma cells through apoptosis signal-regulating kinase 1 pathway. J. Cell. Biochem., 2011.
87. Forester, S.C.; Lambert, J.D. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol. Nutr. Food Res., 2011.
88. Galati, G.; Lin, A.; Sultan, A.M.; O'Brien, P.J. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic. Biol. Med., 2006, 40(4), 570-580.
89. Ahmad, N.; Feyes, D.K.; Nieminen, A.L.; Agarwal, R.; Mukhtar, H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst., 1997, 89(24), 1881-1886.
90. Nihal, M.; Roelke, C.T.; Wood, G.S. Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG). Pharm. Res., 2010, 27(6), 1103-1114.
91. Gupta, S.; Hussain, T.; Mukhtar, H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch. Biochem. Biophys., 2003, 410(1), 177-185.
92. Somers-Edgar, T.J.; Scandlyn, M.J.; Stuart, E.C.; Le Nedelec, M.J.; Valentine, S.P.; Rosengren, R.J. The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo. Int. J. Cancer, 2008, 122(9), 1966-1971.
93. Sánchez, Y.; Calle, C.; de Blas, E.; Aller, P. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases. Chem. Biol. Interact., 2009, 182(1), 37-44.
94. Bandele, O.J.; Osheroff, N. (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases. Chem. Res. Toxicol., 2008, 21(4), 936-943.
95. Bishayee, A.; Háznagy-Radnai, E.; Mbimba, T.; Sipos, P.; Morazzoni, P.; Darvesh, A.S.; Bhatia, D.; Hohmann, J. Anthocyanin-rich black currant extract suppresses the growth of human hepatocellular carcinoma cells. Nat. Prod. Commun., 2010, 5(10), 1613-1618.
96. Yun, J.M.; Afaq, F.; Khan, N.; Mukhtar, H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, induces apoptosis and cell cycle arrest in human colon cancer HCT116 cells. Mol. Carcinog., 2009, 48(3), 260-270.
97. Zava, D.T.; Duwe, G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer, 1997, 27(1), 31-40.
98. Su, S.J.; Yeh, T.M.; Lei, H.Y.; Chow, N.H. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin. Cancer Res., 2000, 6(1), 230-236.
99. Pagliacci, M.C.; Smacchia, M.; Migliorati, G.; Grignani, F.; Riccardi, C.; Nicoletti, I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer, 1994, 30A(11), 1675-1682.
100. Casagrande, F.; Darbon, J.M. p21CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells. Exp. Cell. Res., 2000, 258(1), 101-108.
101. Kuzumaki, T.; Kobayashi, T.; Ishikawa, K. Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem. Biophys. Res. Commun., 1998, 251(1), 291-295.
102. Kazi, A.; Daniel, K.G.; Smith, D.M.; Kumar, N.B.; Dou, Q.P. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem. Pharmacol., 2003, 66(6), 965-976.
103. Bandele, O.J.; Osheroff, N. Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry, 2007, 46(20), 6097-6108.
104. Bektic, J.; Guggenberger, R.; Eder, I.E.; Pelzer, A.E.; Berger, A.P.; Bartsch, G.; Klocker, H. Molecular effects of the isoflavonoid genistein in prostate cancer. Clin. Prostate. Cancer, 2005, 4(2), 124-129.
105. Trochon, V.; Blot, E.; Cymbalista, F.; Engelmann, C.; Tang, R.; Thomaïdis, A.; Vasse, M.; Soria, J.; Lu, H.; Soria, C. Apigenin inhibits endothelial-cell proliferation in G(2)/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression. Int. J. Cancer, 2000, 85(5), 691-696.
106. Neuhaus, T.; Pabst, S.; Stier, S.; Weber, A.; Schrör, K.; Sachinidis, A.; Vetter, H.; Ko, Y. Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. Eur. J. Pharmacol., 2004, 483(2-3), 223-227.
107. Kojima-Yuasa, A.; Hua, J.; Kennedy, D.; Matsui-Yuasa, I. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci., 2003, 73(10), 1299-1313.
108. Martin, S.; Giannone, G.; Andriantsitohaina, R.; Martinez, M.C. Delphinidin, an active compound of red wine, inhibits endothelial cell apoptosis via nitric oxide pathway and regulation of calcium homeostasis. Br. J. Pharmacol., 2003, 139(6), 1095-1102.
109. Favot, L.; Martin, S.; Keravis, T.; Andriantsitohaina, R.; Lugnier, C. Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis. Cardiovasc. Res., 2003, 59(2), 479-487.
110. Xiang, Q.; Lin, G.; Xu, J.; Zheng, S.; Chen, S.; Zhou, K.; Wang, T. The role of caveolin1 and sprouty1 in genistein's regulation of vascular smooth muscle cell and endothelial cell proliferation. Eur. J. Pharmacol., 2010, 648(1-3), 153-161.
111. Sha, G.H.; Lin, S.Q. Genistein inhibits proliferation of human endometrial endothelial cell in vitro. Chin. Med. Sci. J., 2008, 23(1), 49-53.
112. Sandoval, M.; Cutini, P.; Rauschemberger, M.; Massheimer, V. The soyabean isoflavone genistein modulates endothelial cell behaviour. Br. J. Nutr., 2010, 104(2), 171-179.
113. Xu, S.Z.; Zhong, W.; Ghavideldarestani, M.; Saurabh, R.; Lindow, S.W.; Atkin, S.L. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury. Free Radic. Biol. Med., 2009, 47(2), 167-175.
114. Gordon, M.S.; Mendelson, D.S.; Kato, G. Tumor angiogenesis and novel antiangiogenic strategies. Int. J. Cancer, 2010, 126(8), 1777-1787.
115. Liu, L.Z.; Fang, J.; Zhou, Q.; Hu, X.; Shi, X.; Jiang, B.H. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol. Pharmacol., 2005, 68(3), 635-643.
116. Fang, J.; Xia, C.; Cao, Z.; Zheng, J.Z.; Reed, E.; Jiang, B.H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J., 2005, 19(3), 342-353.
117. Fang, J.; Zhou, Q.; Liu, L.Z.; Xia, C.; Hu, X.; Shi, X.; Jiang, B.H. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis, 2007, 28(4), 858-864.
118. Larsen, C.A.; Dashwood, R.H.; Bisson, W.H. Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance. Pharmacol. Res., 2010, 62(6), 457-464.
119. Shimizu, M.; Shirakami, Y.; Sakai, H.; Yasuda, Y.; Kubota, M.; Adachi, S.; Tsurumi, H.; Hara, Y.; Moriwaki, H. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem. Biol. Interact., 2010, 185(3), 247-252.
120. Lee, Y.K.; Shanafelt, T.D.; Bone, N.D.; Strege, A.K.; Jelinek, D.F.; Kay, N.E. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia, 2005, 19(4), 513-523.
121. Hwang, J.; Ha, J.; Park, I.; Lee, S.; Baik, H.; Kim, Y.; Park, O. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett., 2007, 247(1), 115-121.
122. Zhou, Y.D.; Kim, Y.P.; Li, X.C.; Baerson, S.R.; Agarwal, A.K.; Hodges, T.W.; Ferreira, D.; Nagle, D.G. Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J. Nat. Prod., 2004, 67(12), 2063-2069.
123. Domingo, D.S.; Camouse, M.M.; Hsia, A.H.; Matsui, M.; Maes, D.; Ward, N.L.; Cooper, K.D.; Baron, E.D. Anti-angiogenic effects of epigallocatechin-3-gallate in human skin. Int. J. Clin. Exp. Pathol., 2010, 3(7), 705-709.
124. Lamy, S.; Blanchette, M.; Michaud-Levesque, J.; Lafleur, R.; Durocher, Y.; Moghrabi, A.; Barrette, S.; Gingras, D.; Béliveau, R. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis, 2006, 27(5), 989-996.
125. Lamy, S.; Beaulieu, E.; Labbé, D.; Bédard, V.; Moghrabi, A.; Barrette, S.; Gingras, D.; Béliveau, R. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/ receptor (PDGF/PDGFR) signaling. Carcinogenesis, 2008, 29(5), 1033-1041.
126. Guo, Y.; Wang, S.; Hoot, D.; Clinton, S. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J. Nutr. Biochem., 2007, 18(6), 408-417.
127. Sasamura, H.; Takahashi, A.; Miyao, N.; Yanase, M.; Masumori, N.; Kitamura, H.; Itoh, N.; Tsukamoto, T. Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma. Br. J. Cancer, 2002, 86(5), 768-773.
128. Sarkar, F.H.; Li, Y. Soy isoflavones and cancer prevention. Cancer Invest., 2003, 21(5), 744-757.
129. Woodhouse, E.C.; Chuaqui, R.F.; Liotta, L.A. General mechanisms of metastasis. Cancer, 1997, 80(8 Suppl.), 1529-1537.
130. Lindenmeyer, F.; Li, H.; Menashi, S.; Soria, C; Lu, H. Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr. Cancer, 2001, 39(1), 139-147.
131. Czyz, J.; Madeja, Z.; Irmer, U.; Korohoda, W.; Hülser, D.F. Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int. J. Cancer, 2005, 114(1), 12-18.
132. Hu, X.W.; Meng, D.; Fang, J. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis, 2008, 29(12), 2369-2376.
133. Kim, M.H. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J. Cell. Biochem., 2003, 89(3), 529-538.
134. Garbisa, S.; Biggin, S.; Cavallarin, N.; Sartor, L.; Benelli, R.; Albini, A. Tumor invasion: molecular shears blunted by green tea. Nat. Med., 1999, 5(11), 1216.
135. Garbisa, S.; Sartor, L.; Biggin, S.; Salvato, B.; Benelli, R.; Albini, A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer, 2001, 91(4), 822-832.
136. Annabi, B.; Lachambre, M.P.; Bousquet-Gagnon, N.; Page, M.; Gingras, D.; Beliveau, R. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta, 2002, 1542(1-3), 209-220.
137. Yamakawa, S.; Asai, T.; Uchida, T.; Matsukawa, M.; Akizawa, T.; Oku, N. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett., 2004, 210(1), 47-55.
138. Zhen, M.C.; Huang, X.H.; Wang, Q.; Sun, K.; Liu, Y.J.; Li, W.; Zhang, L.J.; Cao, L.Q.; Chen, X.L. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. Acta. Pharmacol. Sin., 2006, 27(12), 1600-1607.
139. Hung, C.F.; Huang, T.F.; Chiang, H.S.; Wu, W.B. (-)-Epigallocatechin-3-gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration through multiple mechanisms. J. Cell. Biochem., 2005, 96(1), 183-197.
140. Günther, S.; Ruhe, C; Derikito, M.G.; Böse, G.; Sauer, H.; Wartenberg, M. Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells. Cancer Lett., 2007, 250(1), 25-35.
141. Nagase, H.; Sasaki, K.; Kito, H.; Haga, A.; Sato, T. Inhibitory effect of delphinidin from Solanum melongena on human fibrosarcoma HT-1080 invasiveness in vitro. Planta Med., 1998, 64(3), 216-219.
142. Lamy, S.; Lafleur, R.; Bédard, V.; Moghrabi, A.; Barrette, S.; Gingras, D.; Béliveau, R. Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system. J. Cell. Biochem., 2007, 100(1), 100-111.
143. Zhang, X.; Fei, Z.; Bu, X.; Zhen, H.; Zhang, Z.; Gu, J.; Chen, Y. Expression and significance of urokinase type plasminogen activator gene in human brain gliomas. J. Surg. Oncol., 2000, 74(2), 90-94.
144. Bergan, R.; Kyle, E.; Nguyen, P.; Trepel, J.; Ingui, C; Neckers, L. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin. Clin. Exp. Metastasis., 1996, 14(4), 389-398.
145. Farina, H.G.; Pomies, M.; Alonso, D.F.; Gomez, D.E. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol. Rep., 2006, 16(4), 885-891.
146. Miekus, K.; Madeja, Z. Genistein inhibits the contact-stimulated migration of prostate cancer cells. Cell. Mol. Biol. Lett., 2007.
147. Kumi-Diaka, J.K.; Hassanhi, M.; Merchant, K.; Horman, V. Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells. J. Med. Food, 2006, 9(4), 491-497.
148. El Touny, L.H.; Banerjee, P.P. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res., 2009, 69(8), 3695-3703.
149. Lee, W.Y.; Huang, S.C.; Tzeng, C.C.; Chang, T.L.; Hsu, K.F. Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells. Nutr. Cancer, 2007, 58(2), 239-246.
150. Puli, S.; Lai, J.C.; Bhushan, A. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones. J. Neurooncol, 2006, 79(2), 135-142.
151. Gao, S.; Hu, M. Bioavailability challenges associated with development of anti-cancer phenolics. Mini. Rev. Med. Chem., 2010, 10(6), 550-567.
152. Kay, CD. The future of flavonoid research. Br. J. Nutr., 2010, 104 Suppl 3, S91-S95.
153. Del Bò, C; Ciappellano, S.; Klimis-Zacas, D.; Martini, D.; Gardana, C; Riso, P.; Porrini, M. Anthocyanin absorption, metabolism, and distribution from a wild blueberry-enriched diet (Vaccinium angustifolium) is affected by diet duration in the Sprague-Dawley rat. J. Agric. Food Chem., 2010, 58(4), 2491-2497.
154. McDougall, G.J.; Fyffe, S.; Dobson, P.; Stewart, D. Anthocyanins from red wine--their stability under simulated gastrointestinal digestion. Phytochemistry, 2005, 66(21), 2540-2548.
155. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr., 2000, 130(8S Suppl), 2073S-2085S.
156. Dangles, O.; Dufour, C; Manach, C; Morand, C; Remesy, C. Binding of flavonoids to plasma proteins. Methods Enzymol, 2001, 335, 319-333.
157. Bolli, A.; Marino, M.; Rimbach, G.; Fanali, G.; Fasano, M.; Ascenzi, P. Flavonoid binding to human serum albumin. Biochem. Biophys. Res. Commun., 2010, 398(3), 444-449.
158. Medic-Saric, M.; Rastija, V.; Bojic, M.; Males, Z. From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. Nutr. J., 2009, 8, 33.
159. Shimada, T.; Tanaka, K.; Takenaka, S.; Murayama, N.; Martin, M.V.; Foroozesh, M.K.; Yamazaki, H.; Guengerich, F.P.; Komori, M. Structure-Function Relationships of Inhibition of Human Cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 Flavonoid Derivatives. Chem. Res. Toxicol., 2010.
160. Chen, H.M.; Chang, F.R.; Hsieh, Y.C.; Cheng, Y.J.; Hsieh, K.C.; Tsai, L.M.; Lin, A.S.; Wu, Y.C.; Yuan, S.S. A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species. Free Radic. Biol. Med., 2011.
161. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 2003, 3(10), 768-780.
162. Long, X.; Fan, M.; Bigsby, R.M.; Nephew, K.P. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Mol. Cancer Ther., 2008, 7(7), 2096-2108.
163. Suganuma, M.; Saha, A.; Fujiki, H. New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci., 2011, 102(2), 317-323.
164. Banerjee, S.; Kong, D.; Azmi, A.S.; Wang, Z.; Ahmad, A.; Sethi, S.; Sarkar, F.H. Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. Int. J. Cancer, 2011, 128(5), 1240-1250.
165. Kumar, R.; Verma, V.; Jain, A.; Jain, R.K.; Maikhuri, J.P.; Gupta, G. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. J. Nutr. Biochem., 2010.
166. Dallongeville, J.; Dauchet, L.; de Mouzon, O.; Réquillart, V.; Soler, L.G. Increasing fruit and vegetable consumption: a cost-effectiveness analysis of public policies. Eur. J. Public Health, 2011, 21(1), 69-73.
167. van Duijnhoven, F.J.; Bueno-De-Mesquita, H.B.; Calligaro, M.; Jenab, M.; Pischon, T.; Jansen, E.H.; Frohlich, J.; Ayyobi, A.; Overvad, K.; Toft-Petersen, A.P.; Tjønneland, A.; Hansen, L.; Boutron-Ruault, M.C.; Clavel-Chapelon, F.; Cottet, V.; Palli, D.; Tagliabue, G.; Panico, S.; Tumino, R.; Vineis, P.; Kaaks, R.; Teucher, B.; Boeing, H.; Drogan, D.; Trichopoulou, A.; Lagiou, P.; Dilis, V.; Peeters, P.H.; Siersema, P.D.; Rodríguez, L.; González, C.A.; Molina-Montes, E.; Dorronsoro, M.; Tormo, M.J.; Barricarte, A.; Palmqvist, R.; Hallmans, G.; Khaw, K.T.; Tsilidis, K.K.; Crowe, F.L.; Chajes, V.; Fedirko, V.; Rinaldi, S.; Norat, T.; Riboli E. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut, 2011.
168. Carter, P.; Gray, L.J.; Troughton, J.; Khunti, K.; Davies, M.J. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ, 2010, 341, 4229.
169. Dauchet, L.; Amouyel, P.; Dallongeville, J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology, 2005, 65(8), 1193-1197.
170. Messina, M.J.; Loprinzi, C.L. Soy for breast cancer survivors: a critical review of the literature. J. Nutr., 2001, 131(11 Suppl.), 3095S-3108S.
171. Jefferson, W.N.; Newbold, R.R. Potential endocrine-modulating effects of various phytoestrogens in the diet. Nutrition, 2000, 16(7-8), 658-662.
172. An, J.; Tzagarakis-Foster, C.; Scharschmidt, T.C.; Lomri, N.; Leitman, D.C. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem., 2001, 276(21), 17808-17814.
173. Santell, R.C.; Chang, Y.C.; Nair, M.G.; Helferich, W.G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J. Nutr., 1997, 127(2), 263-269.
174. Wu, A.H.; Yu, M.C.; Tseng, C.C.; Pike, M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer, 2008, 98(1), 9-14.
175. Yonemoto, R.H. Breast cancer in Japan and United States: epidemiology, hormone receptors, pathology, and survival. Arch. Surg., 1980, 115(9), 1056-1062.